Education
About Us
Working with TipRanks
Follow Us
James Paul Scopa Insider Profile
4 Followers
James Paul Scopa, Director at Trivascular Technologies, holds 0.00 shares in Adverum Biotechnologies (Ticker: ADVM), holds 183.08K shares in Aligos Therapeutics (Ticker: ALGS), holds 0.00 shares in Dice Therapeutics (Ticker: DICE).
James Paul Scopa Trivascular Technologies (TRIV)Director
Trivascular Technologies (TRIV)
Director
Ranked #15,885 out of 106,324 Corporate Insiders
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
+27.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of James Paul Scopa's holdings
Insider Roles
Director
Roles that James Paul Scopa holds in companies
Most Profitable Insider Trade
Stock:
Adverum Biotechnologies
(ADVM)
(ADVM)
Rating:Informative Buy
Date:May 06, 2019 - May 06, 2020
Return:+204.70%
The most profitable trade made by James Paul Scopa
James Paul Scopa's Trading History
Trivascular Technologies
Feb 04, 2016
―
Uninformative Sell
―
$0.00
Adverum Biotechnologies
Dec 10, 2025
―
Uninformative Sell
―
$0.00
Aligos Therapeutics
Oct 27, 2023
Director
Uninformative Buy
137.31K
$1.36M
Dice Therapeutics
Aug 09, 2023
―
Uninformative Sell
―
$0.00
Histogen
Aug 01, 2013
―
Uninformative Buy
183.88K
$13.11K
List of latest transactions for each holding click on a transaction to see James Paul Scopa's performance on stock
You May Also Like
James Paul Scopa insider profile FAQ
What is the percentage of profitable transactions made by James Paul Scopa?
The percentage of profitable transactions made by James Paul Scopa is 40%.
What is the average return per transaction made by James Paul Scopa?
The average return per transaction made by James Paul Scopa is 27.70%.
What stocks does James Paul Scopa hold?
James Paul Scopa holds: TRIV, ADVM, ALGS, DICE, HSTOQ stocks.
What was James Paul Scopa’s latest transaction?
James Paul Scopa latest transaction was an Uninformative Sell of ―.
What was James Paul Scopa's most profitable transaction?
James Paul Scopa’s most profitable transaction was an Informative Buy of ADVM stock on May 6, 2019. The return on the trade was 204.70%.
What is James Paul Scopa's role in Trivascular Technologies?
James Paul Scopa's role in Trivascular Technologies is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.